Merck Keytruda plus Padcev improves survival in advanced or metastatic urothelial carcinoma Ruchika Sharma24 Sept 2023 3:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced positive topline results from the Phase 3 KEYNOTE-A39...
Merck gets USFDA priority review for Keytruda plus concurrent chemoradiotherapy for cervical cancer Ruchika Sharma21 Sept 2023 5:33 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for...
Merck gets positive EU CHMP opinion for Keytruda as adjuvant treatment for adults with Non-Small Cell Lung Cancer Ruchika Sharma18 Sept 2023 11:30 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the European Medicines Agency’s Committee for Medicinal...
AstraZeneca declares positive results from trial of Tagrisso plus chemotherapy to treat EGFR-mutated advanced lung cancer Ruchika Sharma12 Sept 2023 1:30 PM ISTCambridge: AstraZeneca has announced positive results from FLAURA2 phase III trial of Tagrisso (osimertinib) in combination with chemotherapy for...
Janssen declares positive topline results from Phase 3 study evaluating RYBREVANT given with, without lazertinib combined with chemotherapy versus chemotherapy alone Ruchika Sharma9 Sept 2023 1:45 PM ISTNew Jersey: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced positive topline results from the three-arm Phase 3 ...
Medical Bulletin 08/September/2023 Isra Zaman8 Sept 2023 3:15 PM ISTHere are the top medical news of the day:People with lung conditions face extra risks from climate changePeople living with lung conditions, such as...
New genes and natural toxins offer hope for cancer patients unresponsive to chemotherapy Isra Zaman8 Sept 2023 9:15 AM ISTScientists from Queen Mary University of London have discovered two new genes that cause head and neck cancer patients to be resistant to...
Atezolizumab monotherapy bests single-agent chemotherapy among patients with advanced non-small-cell lung cancer Dr. Shravani Dali5 Sept 2023 8:00 PM ISTAtezolizumab monotherapy bests single-agent chemotherapy among patients with advanced non-small-cell lung cancer suggests a new study published in...
Higher BMI Linked to Heart Damage during Chemotherapy in Breast Cancer patients Isra Zaman5 Sept 2023 9:30 AM ISTA recent study in the North-East region of Colombia found 11.94% of patients with a high BMI being treated for breast cancer at a regional center...
Roche Alecensa delivers unprecedented Phase III results for people with ALK positive early stage lung cancer Ruchika Sharma4 Sept 2023 1:30 PM ISTBasel: Roche has announced that the Phase III ALINA study evaluating Alecensa (alectinib), compared with platinum-based chemotherapy, met its primary...
Janssen seeks expanded USFDA approval for Rybrevant in combination with chemotherapy Ruchika Sharma29 Aug 2023 12:00 PM ISTRaritan: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a supplemental Biologics License ...
Daiichi Sankyo Enhertu approved in Japan as first HER2 directed therapy for patients with HER2 mutant metastatic lung cancer Ruchika Sharma25 Aug 2023 10:00 AM ISTTokyo: Daiichi Sankyo has announced that ENHERTU (trastuzumab deruxtecan) has been approved in Japan for the treatment of adult patients with...
